B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SLCO1A1

MOLECULAR TARGET

solute carrier organic anion transporter family, member 1a1

UniProt: P46720NCBI Gene: 5057210 compounds

SLCO1A1 (solute carrier organic anion transporter family, member 1a1) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SLCO1A1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Dehydroepiandrosterone Sulfate1.102
2Taurochenodeoxycholic Acid1.102
3Testosterone0.691
4Aldosterone0.691
5Corticosterone0.691
6Estriol0.691
7Quinidine0.691
8Rifamycins0.691
9Rifamycins0.691
10Taurodeoxycholic Acid0.691

About SLCO1A1 as a Drug Target

SLCO1A1 (solute carrier organic anion transporter family, member 1a1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented SLCO1A1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SLCO1A1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.